Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.46 |
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.45 |
| ▸ | PPARG | P37231 | 7/20 | 0.45 |
| ▸ | PPARD | Q03181 | 7/20 | 0.45 |
| ▸ | PPARA | Q07869 | 7/20 | 0.45 |
| ▸ | HDAC11 | Q96DB2 | 5/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.45 |
| ▸ | TLR2 | O60603 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | FABP4 | P15090 | 2/20 | 0.45 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.45 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11648993 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL14809730 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL14810123 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL14809719 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL14809034 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL8744261 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL14809849 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL14809348 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL14810075 | 1.00 | CPB2 (0.50) | CPB2FFAR4FFAR1ALDH1A1CA1 | |
| SCHEMBL4113412 | 0.93 | CA2 (0.48) | CPB2FFAR4FFAR1ALDH1A1CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250152533-A1 | Novel Beta-Alanine Compositions and Methods of Use Thereof | LEGACY CORPORATE LENDING, LLC, AS ADMINISTRATIVE AGENT | 2025-05-15 | — | — | US | disclosed |
| EP-1741767-B2 | Process for the manufacture of diesel range hydrocarbons | NESTE OYJ (FI) | 2023-04-05 | — | — | EP | disclosed |
| EP-1681337-B2 | Method for the manufacture of hydrocarbons | NESTE OIL OYJ (FI) | 2020-05-13 | — | — | EP | disclosed |
| CN-107530270-A | Cosmetics and the concentrate for preparing the cosmetics | GCT有限公司 | 2018-01-02 | — | — | CN | disclosed |
| EP-2990462-A1 | PROCESS FOR THE MANUFACTURE OF DIESEL RANGE HYDROCARBONS | Neste Oil Oyj (FI) | 2016-03-02 | — | — | EP | disclosed |
| EP-2918660-A1 | Process for low-hydrogen-consumption conversion of renewable feedstocks to alkanes | Energy & Environmental Research Center Foundation (US) | 2015-09-16 | — | — | EP | disclosed |
| EP-1741767-B1 | Process for the manufacture of diesel range hydrocarbons | NESTE OIL OYJ (FI) | 2015-07-22 | — | — | EP | disclosed |
| US-20140275670-A1 | PROCESS FOR LOW-HYDROGEN-CONSUMPTION CONVERSION OF RENEWABLE FEEDSTOCKS TO ALKANES | UNITED STATES DEPARTMENT OF ENERGY | 2014-09-18 | — | — | US | disclosed |
| US-8278492-B2 | Process for the manufacture of diesel range hydrocarbons | NESTE OIL OYJ (FI) | 2012-10-02 | — | — | US | disclosed |
| EP-1681337-B1 | Method for the manufacture of hydrocarbons | NESTE OIL OYJ (FI) | 2010-12-01 | — | — | EP | disclosed |
| US-7781124-B2 | Hologram recording material | NITTO DENKO CORPORATION (JP) | 2010-08-24 | — | — | US | disclosed |
| EP-2040685-A2 | SUSTAINED-RELEASE ALCOHOL-RESISTANT MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM COMPRISING ANTI-MISUSE MEANS | Flamel Technologies (FR) | 2009-04-01 | — | — | EP | disclosed |
| US-7491858-B2 | Method for the manufacture of hydrocarbons | FORTUM OYJ (FI) | 2009-02-17 | — | — | US | disclosed |
| US-20080305404-A1 | Which can vary refractive index upon irradiation with visible light laser and exhibits an excellent transparency after the modulation without requiring any conventional complicated procedure; syndiotactic acrylic ester polymer with side chain vinyl group, and specific photopolymerization initiator | NITTO DENKO CORPORATION (JP) | 2008-12-11 | — | — | US | disclosed |
| WO-2007135193-A2 | SUSTAINED-RELEASE ALCOHOL-RESISTANT MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM COMPRISING ANTI-MISUSE MEANS | FLAMEL TECHNOLOGIES (FR) | 2007-11-29 | — | — | WO | disclosed |
| WO-2007003708-A1 | PROCESS FOR THE MANUFACTURE OF DIESEL RANGE HYDROCARBONS | NESTE OIL OYJ (FI) | 2007-01-11 | — | — | WO | disclosed |
| EP-1741767-A1 | Process for the manufacture of diesel range hydrocarbons | Neste Oil OYJ (FI) | 2007-01-10 | — | — | EP | disclosed |
| US-20060161032-A1 | Plant, animal fats and oils converted to diesel fuel by decarboxylation/decarbonylation by heterogeneous elemental transition metal catalysts pre-treated with hydrogen on suports of metal oxides, mesoporous materials, carbonaceous structures; decreased hydrogen consumption | FORTUM OYJ (FI) | 2006-07-20 | — | — | US | disclosed |
| WO-2006075057-A2 | METHOD FOR THE MANUFACTURE OF HYDROCARBONS | NESTE OIL OYJ (FI) | 2006-07-20 | — | — | WO | disclosed |
| EP-1681337-A1 | Method for the manufacture of hydrocarbons | Neste Oil OYJ (FI) | 2006-07-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250152533-A1 | Novel Beta-Alanine Compositions and Methods of Use Thereof | GYS1, PYGM, AADAT | CPB2 212/4885FFAR4 2139/4885FFAR1 683/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.